The prognostic value of the left ventricular ejection fraction (EF) was compared to that of other commonly used indicesseverity of coronary artery disease, left ventricular end-diastolic pressure, cardiac index, and abnormal ECG in 144 patients with coronary artery disease followed for an average of 14 months on medical management. During this period, 14 patients (10%) died. Analysis of the mortality demonstrated that the EF was the most powerful predictor of short-term survival. Thus, patients with three-vessel coronary artery disease and a normal EF (> 0.50) had a significantly lower mortality (12%) than did patients with three-vessel CAD and a reduced EF (33%, P < 0.001). Similar comparisons were observed within the subgroups with abnormal hemodynamics or an abnormal ECG. Therefore, the EF appears to be an important prognostic guide in the medical therapy of coronary artery disease, and is of significantly more discriminant value than other measurements when combined abnormalities exist.
THE SYSTOLIC EJECTION FRACTION, which
relates stroke volume to end-diastolic volume, has been recently shown to be of primary importance in determining the short-term prognosis of patients undergoing coronary revascularization.'13 There is a lack of similar studies involving this measurement in unoperated patients with coronary disease, despite many reports dealing with the prognostic significance of various clinical and angiographic features. [4] [5] [6] [7] [8] [9] [10] [11] [12] Therefore, the purpose of the present study was to compare the short-term prognostic value of the systolic ejection fraction with that of some other commonly used indicesextent of vessel involvement, cardiac index, left ventricular end-diastolic pressure (LVEDP) and the resting ECGin a group of patients with coronary artery disease receiving only medical treatment.
Materials and Methods

Patient Selection
This series is composed of 145 patients evaluated at the Peter Bent Brigham Hospital during the period January, 1972, through January, 1974, and in whom both coronary arteriography and quantitative ventriculographic analysis were performed. (One patient was lost to follow-up, leaving a total of 144.) Each of the patients selected had angiographically documented coronary artery disease (greater than 75% stenosis of at least one major coronary artery system) and was without evidence of significant valvular dysfunction or hypertension. The reasons for the selection of medical rather than surgical therapy, i.e., myocardial revascularization and/or aneurysmectomy, in these patients were as follows: Group 1. Symptoms of angina pectoris were judged not to be severe enough to warrant surgery (37 patients) Group 2. Symptoms believed severe enough but patient refused surgical therapy (4 patients) Group 3. Symptoms believed severe enough but presence of poor distal vasculature and/or diffuse areas of asynergy precluded technically adequate surgical result (22 patients) Group 4. Symptoms believed severe enough but medical therapy advised initially because vessel involvement was usually limited to either right coronary or left circumflex arteries (81 patients)
ECG Findings
ECGs at rest were obtained on the day prior to cardiac catheterization and were reviewed for evidence of either nonspecific ST-T abnormalities, intraventricular conduction delay, axis deviation, or transmural myocardial infarction using standard New York Heart Association criteria.
Cardiac Catheterization Procedures
Right and left heart catheterization, including coronary arteriography and left ventriculography, were performed as described previously." 13 The LVEDP was measwrred 50 msec following the onset of the QRS complex, or (when present) at a clear-cut inflection in the left ventricular diastolic pressure tracing after the "a" wave. Cardiac output was determined by the indocyanine green dye technique and adjusted for body surface area. Systolic ejection fraction was calculated as follows:
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where EDV = end-diastolic volume; ESV = end-systolic volume. The appropriate volumes were derived from sequential end-diastolic and end-systolic angiographic silhouettes of the left ventricle using a grid calibration system and area-length formulae adapted from those of Dodge et al.`4 Regression equations to determine "true" volumes were not employed, however. Forty-three patients were studied with biplane ventriculography, while 101 had ventriculograms performed only in the right anterior oblique projection (RAO). Recent studies from our laboratory have shown no significant difference in volumes derived from single plane or biplane ventriculography,13 although the addition of the left anterior oblique (LAO) view allows a more detailed analysis of segmental left ventricular wall motion. Since the ejection fraction in normal subjects in our laboratory is 0.66 ± 0.15 (mean ± 2 SD), ejection fractions of less than 0.50 (or more than 2 SD from norm) were considered to be subnormal. This is similar to the subnormal value cited by the American Heart Association (< 0.45).15 Selective coronary arteriography was done by either the Sones or Judkins technique utilizing both the RAO and LAO projections.
Follow-up Data
After cardiac catheterization, each of the 144 patients was followed on medical therapy for periods ranging from 3 to 27 months (mean = 14 months). The type of medical therapy was modified as deemed necessary by the local physician and varied from essentially only clinical observation (in 11 cases), to combined programs including exercise, diet, and large-dose propranolol regimens (> 160 mg/day). Individual adherence to the prescribed regimen could not be adequately determined. Follow-up data were obtained from personal and/or written interviews with the patient, family, and private physician. These data included current medications, presence or absence of symptoms of angina pectoris or congestive heart failure, and improvement, worsening, or lack of change in these symptoms in the interval since catheterization. In addition, the occurrence of an interim myocardial infarction or arrhythmia was noted. In the event of a patient's death, data were obtained from family and/or personal physician as to date, probable cause and medications at the time of death. Abbreviations: IVCD = intraventricular conduction defect; MI = myocardial infarction; LAD = left axis deviation; NSST.T = nonspecific ST-T wave abnormalities.
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Results
Initial Profile
The clinical features in the 144 patients are depicted in table 1. As noted, 52 patients had subnormal ejection fractions (37%) and of these, 24 had ejection fractions of less than 0.30 (17%). There was no significant relationship between an abnormal ejection fraction and age, sex, or specific ECG abnormalities such as myocardial infarction using chi-square tests. In regard to presenting symptoms (table 2) , there was a significant relation between NYHA Class III and IV symptoms of congestive heart failure and subnormal ejection fraction. There was, however, no significant relation between ejection fraction and severity of angina pectoris or presence of mild congestive heart failure. There was a significant relation between a subnormal ejection fraction and associated abnormalities of LVEDP, diffuse left ventricular dysfunction on angiographic analysis, and three-vessel coronary artery disease (table 3) . When the ejection fraction was related to the reason for selection of medical therapy, values less than 0.50 were found in two of the 37 patients in group 1, none of the four patients in group 2, 21 of the 22 patients in group 3, and 19 of the 81 patients in group 4.
Patients Dying During Follow-up Period
There were 14 deaths during the follow-up period. Four were sudden while the remainder were attributed to an additional myocardial infarction, progressive congestive heart failure or a combination of the two. None was thought to be noncardiac in etiology. Five patients were receiving high doses of propranolol for severe angina compared to 100 of the 130 survivors. No patients receiving propranolol had an ejection fraction of less than 0.30. As depicted in table 4, the distribution of normal and abnormal ECGs was not significantly different in the surviving patients compared to those who died. Abbreviations: NYHA = New York Heart Association functional classification; CHF = congestive heart failure. Abbreviations: LVEDP = left ventricular end-diastolic pressure; CAD = coronary artery disease; CI = cardiac index; angio = angiogram; seg dys = segmental dysfunction; diff dys = diffuse dysfunction.
There was a significantly higher frequency of an abnormal ejection fraction and combined abnormalities of LVEDP and cardiac index, as well as three-vessel coronary artery disease, in those patients who died compared with the survivors. Although not a statistically significant difference, 12 of the 14 patients dying had an ejection fraction less than 0.50 (86%) including ten with an ejection fraction less than 0.30 (71%), while only nine (64%) and eight (57%) had three-vessel disease or combined abnormalities of Abbreviations: NSST.T = nonspecific ST.T wave abnormalities; IVCD = intraventricular conduction defect; LAD = left axis deviation; MI = myocardial infaretion; LVEDP = left ventricular end-diastolic pressure: CI = cardiac index; CAD = coronary artery disease; EF = ejection fraction. LVEDP and cardiac index, respectively. When mortality was related to reason for selection for medical therapy, nine of the 14 patients were in group 3 compared to one in group 1 and two each in groups 2 and 4.
In order to further evaluate the prognostic significance of these measurements, normal and abnormal values for ejection fraction were related to mortality in all patients and then in those patients with three-vessel disease, one-vessel disease, and combined abnormalities of LVEDP and cardiac index ( fig.  1) . In the over-all group, the percent mortality among the 52 patients with an ejection fraction less than 0.50 was 24%, and rose to 42% in the 24 patients with an ejection fraction less than 0.30. This was significantly higher than the mortality of 2% in the 92 patients with a normal ejection fraction (P < 0.001). The 37 patients with three-vessel disease had an over-all mortality of 24%, identical to that of the group with subnormal ejection fraction. However, when this group was subdivided into those with normal or abnormal ejection fractions, the increase in mortality was almost entirely among those patients who also had a reduced ejection fraction. Thus, 21 patients with three-vessel disease and an ejection fraction less than 0.50 had a mortality of 33% (which increased to 56% in the 11 patients with an ejection fraction less than 0.30), while among the 16 patients with three-vessel disease but a normal ejection fraction the mortality was only 12% (P < 0.001). In addition, although the mortality among the 81 patients with one-vessel disease was only 5%, it increased to 21% in the 19 patients with an ejection fraction less than 0.50 and to 50% in the five patients with an ejection fraction less than 0.30. These patients all had occlusions of the left anterior descending artery and large aneurysms. By contrast, the mortality in the 62 patients with one-vessel disease Mortality related to ejection fraction (EF) alone, and EF combined with three-vessel coronary artery disease (CAD), one vessel CAD, and abnormalities of left ventricular end-diastolic pressure (EDP) and cardiac index (CI). In each instance, mortality with EF < 0.50 was significantly greater (P < 0.001) than mortality with EF > 0.50. Highest mortality was observed when EF was < 0.30.
Circulation, Volume 52, September 1975 and a normal ejection fraction was zero (P < 0.001). The mortality among the 29 patients with combined abnormalities of LVEDP and cardiac index was 27%. In this case, subdivision by ejection fraction demonstrated the increase in mortality to be wholly among the 21 patients with associated depression of ejection fraction, while there were no deaths among the eight patients with combined abnormalities of LVEDP and cardiac index but normal ejection fractions (P < 0.001). Similarly, the mortality in patients with abnormal ECGs was 12% and was largely confined to patients who also had abnormal ejection fractions.
Survival Group
Further evaluation of those patients surviving over the follow-up period demonstrated subjective improvement in symptoms in 54%, with 28% reporting no change and 18% noting worsening of symptoms. Division of the survival group by ejection fraction, extent of coronary artery disease and combined LVEDP and cardiac index as done previously revealed no significant differences in the numbers of patients reporting improvement or worsening of symptoms within these groups when compared with the incidence in the over-all group. There were nine patients in the survival group in whom interim infarction occurred. All had normal ejection fractions on initial evaluation. Two of these patients noted improvement in their symptoms postinfarct, four were unchanged, while three noted worsening of symptoms. Of the six patients having either no change or improvement in symptoms following infarction, five had previously had one-vessel coronary artery disease, while among those noting worsening of symptoms, two had three-vessel coronary artery disease initially while only one had one-vessel coronary artery disease.
Discussion
While the need to precisely delineate the natural history of ischemic heart disease in an individual patient has resulted in the critical evaluation of many different clinical features,4-8 the majority of recent reports have emphasized extent of coronary artery disease as determined by angiography as the primay predictor of mortality.9-12 However, two groups1" 12 have also shown that qualitative analysis of the left ventriculogram can further discriminate among patients with one, two, and three-vessel disease in regard to five-year mortality. Although uantitative analysis was not performed in these studies, Murray et al.,'6 in a preliminary report, have emphasized the role of the systolic ejection fraction in defining a group of patients with medically treated coronary artery disease whose mortality was significantly higher than that of the over-all group.
Circulation, Volume 52, September 1975 In the present study, we have compared the prognostic significance of a reduced ejection fraction to that of triple vessel disease and observed that not only was the ejection fraction a more sensitive predictor of mortality, but it was possible to differentiate high-risk and low-risk patients within the three-vessel group, based on the ejection fraction. This emphasizes the role of left ventricular contractile function as the most powerful predictor of short-term survival in patients with coronary artery disease regardless of the selected therapy or extent of vessel involvement. Our data also confirm the observation of Cohn et al.' of the greater reliability of the ejection fraction as a prognostic guide to residual left ventricular function in patients undergoing cardiac surgery than either LVEDP, cardiac index, or a combination of the two. This is not surprising, since LVEDP may be influenced by both ventricular volume and compliance while cardiac output is a function of numerous unrelated variables (venous return, aortic impedance, heart rate, stroke volume). An abnormal ejection fraction was also more sensitive than an abnormal resting ECG in predicting mortality in this study (24% vs 12%) and most of the patients with ECG abnormalities who died also had low ejection fractions. Thus, the finding of an intraventricular conduction defect or myocardial infarction may not in itself adversely affect prognosis.
It was of interest that the worst prognosis was in those patients who were treated medically because they were technically inoperable but who had severe symptoms (group 3). Nearly all of these patients had abnormal ejection fractions. Patients with normal ejection fractions and mild symptoms and/or limited coronary disease may have good short-term prognoses, but their long-term outlook will require further evaluation.
